Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
230 studies found for:    rsv
Show Display Options
Rank Status Study
1 Recruiting Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Drug: VXA-RSV-f Oral Vaccine;   Drug: VXA Placebo Tablets
2 Active, not recruiting A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
3 Completed Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: normal saline
4 Recruiting A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Condition: Respiratory Syncytial Virus (RSV)
Intervention: Drug: Palivizumab
5 Completed Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Saline Placebo
6 Completed RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: Saline Placebo (0.5mL injection);   Drug: RSV F vaccine (0.5mL injection)
7 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
8 Completed Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: Normal Saline
9 Active, not recruiting Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
10 Completed Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis
Condition: RSV Bronchiolitis
Intervention: Drug: Azithromycin
11 Completed
Has Results
Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
Condition: Respiratory Syncytial Virus (RSV)
Intervention:
12 Completed Intra-nasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV)
Condition: RSV Infection
Interventions: Drug: MEDI-557;   Other: Placebo
13 Completed Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: ALN-RSV01
14 Not yet recruiting RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA-BN-RSV;   Other: Placebo
15 Completed A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
Condition: Healthy Participants
Interventions: Biological: Ad35.RSV.FA2;   Biological: Ad26.RSV.FA2;   Drug: Placebo
16 Completed Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA BN RSV;   Other: Placebo
17 Completed Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
18 Completed Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
19 Completed A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
Conditions: Respiratory Syncytial Viruses;   Respiratory Tract Infections
Interventions: Biological: Ad26.RSV.FA2;   Biological: Ad35.RSV.FA2;   Drug: Placebo
20 Recruiting Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
Condition: Respiratory Syncytial Virus, Bronchiolitis
Interventions: Drug: Oral azithromycin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.